GSK pays $500M for rights to drugs from Chinese firm Hengrui
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
A major meta-analysis finds that patients who discontinue anti-obesity medications quickly regain weight, yet, crucially, they still retain some of ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that ...
A Kura Oncology and Kyowa Kirin-partnered drug vying to become the first FDA-approved treatment for cases of acute myeloid leukemia ...
The global conversation around weight loss has shifted rapidly over the past few years. Once dominated by gym regimens and ...
Indianapolis-based pharmaceutical behemoth Eli Lilly has filed lawsuits against four compounders claiming that they sold unapproved products that contain tirzepatide, ...
Credit: Pixabay/CC0 Public Domain The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients ...
NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of ...
BridgeBio Oncology Therapeutics, a company working to advance the field of therapies addressing a validated but elusive group of cancer ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.